H. Gadner

M. Schemper, O. Delattre, H. Kovar, 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

Autoantibodies in chronic GVHD: high prevalence of antinucleolar antibodies.

J. Węsierska‐Gądek, S. Bakos, E. Penner, 1990, Bone marrow transplantation.

Prednisone response is the strongest predictor of treatment outcome in infant acute lymphoblastic leukemia.

A. Borkhardt, M. Schrappe, W. Ludwig, 1999, Blood.

Effective childhood cancer treatment: The impact of large scale clinical trials in Germany and Austria

F. Berthold, B. Burkhardt, U. Dirksen, 2013, Pediatric blood & cancer.

Intratumoural heterogeneity of 1p deletions and MYCN amplification in neuroblastomas.

B. Bernardi, H. Kovar, P. Ambros, 2001, Medical and pediatric oncology.

Successful treatment strategy for Ki-1 anaplastic large-cell lymphoma of childhood: a prospective analysis of 62 patients enrolled in three consecutive Berlin-Frankfurt-Munster group studies.

M. Tiemann, M. Schrappe, R. Parwaresch, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Treatment with all-trans retinoic acid in acute promyelocytic leukemia reduces early deaths in children

D. Reinhardt, H. Gadner, G. Mann, 2001, Annals of Hematology.

Improved treatment results in high-risk pediatric acute myeloid leukemia patients after intensification with high-dose cytarabine and mitoxantrone: results of Study Acute Myeloid Leukemia-Berlin-Frankfurt-Münster 93.

F. Berthold, G. Henze, D. Reinhardt, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Short-pulse B-non-Hodgkin lymphoma-type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: a report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90.

M. Tiemann, M. Schrappe, R. Parwaresch, 2001, Blood.

G-CSF versus GM-CSF for stimulation of peripheral blood progenitor cells (PBPC) and leukocytes in healthy volunteers: comparison of efficacy and tolerability

O. Haas, O. Haas, D. Printz, 1999, Annals of Hematology.

Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission after intensive primary and relapse therapy according to the BFM- and CoALL-protocols: results of the German Cooperative Study.

W. Friedrich, G. Henze, T. Klingebiel, 1991, Blood.

Phase I study of tumor Ag-loaded IL-12 secreting semi-mature DC for the treatment of pediatric cancer.

T. Felzmann, H. Gadner, W. Holter, 2007, Cytotherapy.

The Seventh International Childhood Acute Lymphoblastic Leukemia Workshop Report: Palermo, Italy, January 29–30, 2005

C. Pui, R. Pieters, A. Baruchel, 2005, Leukemia.

Lineage-specific chimaerism after stem cell transplantation in children following reduced intensity conditioning: potential predictive value of NK cell chimaerism for late graft rejection

F. Frommlet, T. Lion, M. König, 2003, Leukemia.

High-dose therapy for patients with primary multifocal and early relapsed Ewing's tumors: results of two consecutive regimens assessing the role of total-body irradiation.

J. Haerting, J. Dunst, S. Burdach, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Management of immune thrombocytopenic purpura in children.

H. Gadner, H. Gadner, 2001, Reviews in clinical and experimental hematology.

Detection and clinical relevance of genetic abnormalities in pediatric acute lymphoblastic leukemia: a comparison between cytogenetic and polymerase chain reaction analyses.

T. Lion, J. Harbott, O. Haas, 1993, Leukemia.

Detection of Disseminated Tumor Cells in Neuroblastoma: 3 Log Improvement in Sensitivity by Automatic Immunofluorescence plus FISH (AIPF) Analysis Compared with Classical Bone Marrow Cytology

Ruth Ladenstein, Peter F Ambros, P. Ambros, 2003 .

Multivariate analysis of risk factors in stage 4 neuroblastoma patients over the age of one year treated with megatherapy and stem-cell transplantation: a report from the European Bone Marrow Transplantation Solid Tumor Registry.

D. Frappaz, T. Klingebiel, F. Chauvin, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Risk factors for diabetes insipidus in langerhans cell histiocytosis

U. Pötschger, H. Prosch, H. Gadner, 2006, Pediatric blood & cancer.

Induction death and treatment-related mortality in first remission of children with acute lymphoblastic leukemia: a population-based analysis of the Austrian Berlin-Frankfurt-Münster study group

B. Meister, A. Attarbaschi, O. Haas, 2009, Leukemia.

Prevention of CNS recurrence in childhood ALL: Results with reduced radiotherapy combined with CNS-directed chemotherapy in four consecutive ALL-BFM trials

M. Schrappe, G. Henze, C. Niemeyer, 1998, Klinische Padiatrie.

Teratomas in infancy and childhood.

H. Gadner, D. Harms, U. Göbel, 1998, Medical and pediatric oncology.

The eighth international childhood acute lymphoblastic leukemia workshop (‘Ponte di Legno meeting’) report: Vienna, Austria, April 27–28, 2005

C. Pui, M. Schrappe, G. Masera, 2006, Leukemia.

Improved outcome of treatment-resistant high-risk Langerhans cell histiocytosis after allogeneic stem cell transplantation with reduced-intensity conditioning

A. Attarbaschi, H. Gadner, W. Holter, 2005, Bone Marrow Transplantation.

Langerhans cell histiocytosis in neonates

U. Pötschger, H. Prosch, H. Gadner, 2005, Pediatric blood & cancer.

Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood

W. Hop, W. Kamps, J. V. van Dongen, 1998, The Lancet.

Transplantation of highly purified peripheral blood CD34+ cells from HLA-mismatched parental donors in 14 children: evaluation of early monitoring of engraftment

T. Lion, T. Klingebiel, P. Höcker, 1999, Leukemia.

Results of treatment for soft tissue sarcoma in childhood and adolescence: a final report of the German Cooperative Soft Tissue Sarcoma Study CWS-86.

G. Henze, H. Jürgens, T. Klingebiel, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Autologous bone-marrow transplants compared with chemotherapy for children with acute lymphoblastic leukaemia in a second remission: a matched-pair analysis

G. Henze, F. Zintl, W. Ebell, 1995, The Lancet.

Wilms' tumour gene (wt1) expression at diagnosis has no prognostic relevance in childhood acute lymphoblastic leukaemia treated by an intensive chemotherapy protocol

G. Heinze, T. Lion, O. Haas, 1999, European journal of haematology.

Treatment of multisystem Langerhans cell histiocytosis. Results of the DAL-HX 83 and DAL-HX 90 studies. DAL-HX Study Group.

U. Pötschger, H. Gadner, M. Minkov, 2000, Klinische Padiatrie.